X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5283) 5283
Book Review (756) 756
Publication (496) 496
Conference Proceeding (92) 92
Book Chapter (74) 74
Dissertation (26) 26
Book / eBook (4) 4
Trade Publication Article (4) 4
Government Document (3) 3
Web Resource (2) 2
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3836) 3836
humans (3636) 3636
cll (3060) 3060
hematology (2317) 2317
oncology (1969) 1969
male (1721) 1721
female (1654) 1654
middle aged (1526) 1526
aged (1506) 1506
chronic lymphocytic leukemia (1319) 1319
leukemia, lymphocytic, chronic, b-cell - pathology (1103) 1103
leukemia, lymphocytic, chronic, b-cell - genetics (1047) 1047
adult (940) 940
leukemia, lymphocytic, chronic, b-cell - drug therapy (840) 840
aged, 80 and over (823) 823
b-cll (785) 785
apoptosis (784) 784
prognosis (772) 772
leukemia (754) 754
cancer (699) 699
chronic lymphocytic-leukemia (682) 682
expression (676) 676
survival (658) 658
leukemia, lymphocytic, chronic, b-cell - immunology (614) 614
leukemia, lymphocytic, chronic, b-cell - metabolism (604) 604
fludarabine (534) 534
animals (505) 505
flow cytometry (477) 477
rituximab (461) 461
mutation (442) 442
leukemia, lymphocytic, chronic, b-cell - diagnosis (427) 427
hemic and lymphatic diseases (420) 420
lymphoma (394) 394
therapy (384) 384
activation (374) 374
disease progression (374) 374
b-cell cll-lymphoma 10 protein (359) 359
leukemia, lymphocytic, chronic, b-cell - mortality (359) 359
leukemia, lymphocytic, chronic, b-cell - therapy (339) 339
mice (338) 338
research (338) 338
treatment outcome (336) 336
diagnosis (335) 335
cd38 expression (322) 322
cell biology (310) 310
care and treatment (308) 308
abridged index medicus (300) 300
antineoplastic agents - therapeutic use (300) 300
chronic lymphatic leukemia (300) 300
immunology (294) 294
immunophenotyping (290) 290
disease (286) 286
signal transduction (285) 285
b-cells (282) 282
tumor cells, cultured (282) 282
genetic aspects (280) 280
analysis (278) 278
vidarabine - analogs & derivatives (277) 277
antineoplastic combined chemotherapy protocols - therapeutic use (272) 272
lymphomas (269) 269
leukemia, lymphocytic, chronic, b-cell - blood (264) 264
in-vitro (263) 263
apoptosis - drug effects (257) 257
article (257) 257
ibrutinib (254) 254
pathology (247) 247
hematology, oncology and palliative medicine (244) 244
cyclophosphamide (242) 242
b-lymphocytes - immunology (240) 240
b-lymphocytes - pathology (239) 239
chronic lymphocytic leukaemia (235) 235
gene expression (230) 230
cll cells (228) 228
cells (227) 227
cell line, tumor (223) 223
chemotherapy (223) 223
gene (214) 214
antineoplastic agents - pharmacology (208) 208
b-lymphocytes - metabolism (207) 207
t-cells (204) 204
proteins (203) 203
immune system diseases (200) 200
nf-kappa b - metabolism (199) 199
biochemistry & molecular biology (198) 198
neoplasm staging (196) 196
medicine, research & experimental (195) 195
phosphorylation (194) 194
medicine & public health (190) 190
neoplasm proteins - genetics (190) 190
genes (187) 187
risk factors (187) 187
lymphocytes (186) 186
immunotherapy (185) 185
lymphatic leukemia (185) 185
alemtuzumab (179) 179
nf-kappa-b (179) 179
proliferation (179) 179
chromosome aberrations (178) 178
leukemia, lymphocytic, chronic, b-cell - complications (178) 178
health aspects (177) 177
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5212) 5212
French (44) 44
Polish (35) 35
German (33) 33
Japanese (18) 18
Russian (18) 18
Chinese (17) 17
Czech (11) 11
Spanish (9) 9
Korean (8) 8
Turkish (6) 6
Portuguese (4) 4
Hungarian (3) 3
Italian (3) 3
Romanian (3) 3
Dutch (2) 2
Icelandic (2) 2
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Surgical Pathology, ISSN 0147-5185, 12/2015, Volume 39, Issue 12, pp. 1653 - 1660
Journal Article
BLOOD, ISSN 0006-4971, 11/2018, Volume 132, Issue 21, pp. 2212 - 2213
In this issue of Blood, deWeerdt et al report that in chronic lymphocytic leukemia (CLL) patients, the gamma delta T cells are functionally compromised. These... 
CLL | IBRUTINIB | INHIBITOR | HEMATOLOGY
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 05/2015, Volume 13, Issue 5.5, pp. 662 - 665
The decision of when to start treatment for patients with chronic lymphocytic leukemia (CLL) has not markedly changed; it is triggered by parameters of active... 
CLL | ONCOLOGY
Journal Article
11/2012
The ability of cancer cells to escape anti-tumor immune responses is acknowledged as one of the hallmarks of cancer. Overexpression of immunoregulatory... 
CLL | 0992 | 0982 | immunotherapy | CD200
Dissertation
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, ISSN 1083-8791, 3/2018, Volume 24, Issue 3, pp. 581 - 586
Chronic lymphocytic leukemia (CLL) is a common hematologic malignancy with many highly effective therapies. Chemorefractory disease, often characterized by... 
CLL | allogeneic transplant | HLA
Journal Article
BLOOD, ISSN 0006-4971, 07/2019, Volume 134, Issue 2, pp. 111 - 122
To define the efficacy of venetoclax with extended follow-up and identify clinical or biological treatment effect modifiers, updated data for previously... 
BCL2 | CLL | INHIBITOR | HEMATOLOGY | RITUXIMAB
Journal Article
HAEMATOLOGICA, ISSN 0390-6078, 08/2018, Volume 103, Issue 9, pp. 1511 - 1517
Venetoclax is a BCL2 inhibitor approved for 17 deleted relapsed/refractory chronic lymphocytic leukemia with activity following kinase inhibitors. We conducted... 
MULTICENTER | CLL | IBRUTINIB | BCL2 | HEMATOLOGY
Journal Article
02/2012
To find gene expression patterns in disease and biological processes the use of DNA microarrays has already begun to have a significant impact on modern... 
ALL | CLL | malignancy | gene profiling | lymphoma | malignant lymphoma
Web Resource
Haematologica, ISSN 0390-6078, 02/2017, Volume 102, Issue 3, pp. 562 - 572
Chronic lymphocytic leukemia is characterized by impaired immune functions largely due to profound T-cell defects. T-cell functions also depend on co-signaling... 
CD152 CTLA-4 | CLL PATIENTS | STAGE | EXPANSION | SURFACE EXPRESSION | SUBSETS | LENALIDOMIDE | PERIPHERAL-BLOOD | HEMATOLOGY | PD-1 | B-CLL | T-Lymphocyte Subsets - immunology | Prognosis | Humans | Middle Aged | Immunomodulation - genetics | Male | Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Biomarkers, Tumor | Case-Control Studies | Female | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | CTLA-4 Antigen - metabolism | Programmed Cell Death 1 Receptor - metabolism | CTLA-4 Antigen - genetics | Immunophenotyping | Tumor Necrosis Factor Receptor Superfamily, Member 9 - metabolism | Gene Expression Regulation, Leukemic | Disease Progression | Leukemia, Lymphocytic, Chronic, B-Cell - therapy | Drug Resistance, Neoplasm - genetics | Phenotype | T-Lymphocyte Subsets - metabolism | Chromosome Aberrations | Biomarkers | Lymphocyte Count | Aged | Mutation | Programmed Cell Death 1 Receptor - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - diagnosis | Index Medicus | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Medicin och hälsovetenskap | Molekylär medicin | Molecular Medicine | Klinisk medicin | SURFACE EXPRESSION; PERIPHERAL-BLOOD; CD152 CTLA-4; CLL PATIENTS; B-CLL; EXPANSION; SUBSETS; STAGE; PD-1; LENALIDOMIDE
Journal Article
BRITISH JOURNAL OF HAEMATOLOGY, ISSN 0007-1048, 03/2019, Volume 185, pp. 87 - 87
Conference Proceeding
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 16, pp. 13023 - 13035
GDC-0853 is a selective, reversible, and non-covalent inhibitor of Bruton's tyrosine kinase (BTK) that does not require interaction with the Cys481 residue for... 
BTK | CLL | GCD0853
Journal Article
Oncotarget, ISSN 1949-2553, 09/2018, Volume 9, Issue 72, pp. 33710 - 33718
Signal transducer and activator of transcription (STAT)-3 might be phosphorylated or acetylated. Unlike the phosphorylation of STAT3, little is known about the... 
CLL | STAT3 | Acetylation
Journal Article
Life Sciences, ISSN 0024-3205, 09/2019, Volume 232, pp. 116583 - 116583
TP53 mutation is an indicator of poor prognostic in chronic lymphocytic leukemia (CLL). Worse still, CLL patients with TP53 mutation are associated with poor... 
Entinostat | CLL | HO-1 | Drug-resistance | Combination therapy
Journal Article
11/2010
Aim: To investigate the usefulness of some clinical and laboratory parameters in assessing the prognosis and survival of CLL in a resource-limited setting.... 
resource-limited setting | CLL | diagnostic problems
Web Resource
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.